chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PT DESCRIBED PAIN RADIATING FROM ARM PIT TO NECK ON LEFT SIDE.  LYMPH NODES REPORTED AS SWOLLEN AND PAINFUL.  PT REPORTS LOW GRADE TEMPERATURE.  PT REPORTS "BLOTCHY" AREAS TO LEFT UPPER ARM, AREA ABOVE ARMPIT AND SHOULDER.
Initial report was received 14 September 2010 from a health care professional. A four-year-old female patient had received an injection of DECAVAC (route and site not reported), lot number C3381AA (lot number invalid for DECAVAC, but valid for DAPTACEL) on 09 September 2010 and an unspecified amount of time later that same day, she developed redness and swelling at the vaccination site. The redness and swelling then progressed to her elbow. By 11 September 2010, she developed swelling of the entire arm, hand and fingers. The patient was diagnosed with cellulitis and had two hospital visits for treatment with antibiotics. During her first visit, she received intravenous Vancomycin, and then developed an allergic reaction and received unspecified treatment. During her second visit, she received intravenous KEFLEX. According to the reporter, the swelling was resolving, but had not completely resolved at the time of the report. Documents held by sender: None.
Heaviness in right side. Reduced movement in fingers on right hand. Muscular stiffness in right side. Feeling numb on side of injection. Getting sore after very little physical activity. It's been 17 days since injection of Gardasil. Movements getting harder each day.
My crohns started flaring up after being in remission. I also started bleeding in my stool.
I had just recovered from a case of shingles when I contracted Covid19 on 5/12/2022 with symptoms of weakness, runny nose, congestion, cough, fatigue, fever of 100 at highest point, loss of appetite. I was prescribed Paxlovid on 5/14/2022 and have experienced a metallic taste in my mouth since beginning the anti viral medication. I also received monoclonal antibodies 5/16/2022. My symptoms are beginning to resolve.
Pt tested positive for COVID-10 after received fully vaccinated: Dose 1 date: 12/31/2020 Dose 2 date: 1/21/2021
I got my first shot on 1-6-21 and did not get my 2nd one; over 6 Months since first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I got my first shot on 1-6-21 and did not get my 2nd one) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (over 6 Months since first dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I got my first shot on 1-6-21 and did not get my 2nd one) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (over 6 Months since first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I got my first shot on 1-6-21 and did not get my 2nd one) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (over 6 Months since first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were mentioned by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 11-Aug-2021: non-significant follow up received on 11-AUG-2021 and contains No new information was updated.
Pt developed hematoma at point of vaccine administration, upon removing the needle patient bled more than usual for a vaccine and developed a hematoma. Pt was monitored for approximately one hour, hematoma did not worsen. Pt was advised on care and to seek medical attention should the hematoma worsen. Pt did not complain of pain or any other side effects/symptoms.
PARTIAL INJECTION OF VACCINE DOSE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. the batch lot number were not reported hence requested No concomitant medications were reported. On 06-MAR-2021, the subject experienced partial injection of vaccine dose. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of partial injection of vaccine dose was not reported. This report was non-serious.
Sore Arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore Arm) and CHILLS (Chills) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 010M20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, LISINOPRIL and ATORVASTATIN for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore Arm) and CHILLS (Chills). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of 1 dosage form. On 12-Feb-2021, VACCINATION SITE PAIN (Sore Arm) and CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-223842 (Patient Link).
on the day of the vaccine my right was arm and the area where I received the vaccine was red, the next day the pain decreased and was almost gone by the end of the day. But on 02/17/21 at work I discovered a small bump on my right side bonecollar, without knowing what it was as I never felt it before, I decided to go to the doctor, she said it is a lymph node swelling and is about 1.5cm and could possibly be a result of the COVID-19 vaccine and that she believes it'll disappear within the  next few days and might have the same results after the second vaccine.
I woke up at 5:00 am on Wednesday with a horrible headache and extremely painful body aches.  My temperature stayed right around 99.8 but never got as high as it was the first time around.  My left arm was extremely sore to the touch and it hurt to move it above my waist for most of the day.   Similar to my experience after the first vaccination,  taking Tylenol and Motrin were absolutely no help.  I felt very lethargic all day as well.   The worst of the side effects lasted until I woke up on Thursday morning. My arm was still really sore and the body aches were still there but much better. Tylenol worked to alleviate the pain.
Sore arm first two days. Ten days later, swelling at site. Redness, lump, heat and itching
pt inadvertently recv ID hep B vax instead of tuberculin purified protein derivative & exp itching & induration;
Numbness in right side of face and neck, tingling in right hand, pain in right ankle, chills, fatigue. Most symptoms went away on their own within a couple hours. The ankle pain was intermittent for 24 hours after. No medical treatment received, just advised my doctor of the issues.
Gradually worsening extremity weakness over 3-4 weeks, feet-tingling sensation 3 months prior. Improvement of symptoms after IVIG.
Response immediately following GARDASIL injection. Jerking movements of 4 limbs and loss of consciousness - lasted 30-60 seconds with pt. returning to normal with vague feeling of nausea and confusion as to what had occurred. Pt. re-examined by doctor, VS taken, O2 sat NL. Pt was discharged to home.
This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a elderly female patient who received Flu Seasonal QIV Dresden. Co-suspect products included VENTOLIN HFA inhaler for asthma and chronic obstructive pulmonary disease. Concurrent medical conditions included glaucoma. Concomitant products included LEVOTHYROXINE, SINGULAIR, omeprazole, Ropinirole, amlodipine, LOSARTAN, Aspirin, Vitamin D3, TRAVATAN and metoprolol. In October 2017, the patient received Influenza Quadrivalent. On an unknown date, the patient started VENTOLIN HFA (inhaled) 2 puff(s) as needed. In November 2017, less than a year after receiving Influenza vaccine Quadrivalent and unknown after starting VENTOLIN HFA, the patient experienced influenza. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant). VENTOLIN HFA was continued with no change. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the influenza was recovering/resolving.  The reporter considered the vaccination failure and influenza to be unrelated to Influenza vaccine Quadrivalent. The reporter considered the influenza to be unrelated to VENTOLIN Hfa. Additional information was provided as follows: The patient's spouse reported this case. The age at vaccination was not reported. Concomitant medication included ZOLAMIDE. In October 2017, the patient received a flu shot of unknown brand. In November 2017, the patient got sick with the flu. On 11th November 2017, the patient went to the physician. The patient required emergency room visit. The patient was still recovering from the illness. This case was considered a suspected vaccination failure case, as the details regarding the exact time to onset were unknown.
This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt crappy), PAIN IN EXTREMITY (sore arm) and COVID-19 (Tested positive for Covid-19) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.  Concurrent medical conditions included COVID-19 since 28-Apr-2021. Concomitant products included BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE (BISOPROLOL /HCTZ) for Hypertension. On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced FEELING ABNORMAL (felt crappy) and PAIN IN EXTREMITY (sore arm). On 28-Apr-2021, the patient experienced COVID-19 (Tested positive for Covid-19). At the time of the report, FEELING ABNORMAL (felt crappy), PAIN IN EXTREMITY (sore arm) and COVID-19 (Tested positive for Covid-19) outcome was unknown.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Apr-2021, COVID-19: other (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.
Muscle cramping; Pain; Muscle aches; Severe joint aches; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736), via an unspecified route of administration in the left arm on 23Apr2021 at 14:45 (at the age of 47-year-old), as a single dose for COVID-19 immunisation. Medical history included heart attack from July 2020, spinal disorder, back/spinal issues and arthritis. The patient did not have a history of allergies to any food or medications or other products. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), ticagrelor (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN) and acetylsalicylic acid (LOW DOSE ASA) for an unknown indication from an unknown dates. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533), via an unspecified route of administration in the left arm on 02Apr2021 at 10:45 (at the age of 47-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Apr2021 at 18:00, the patient experienced muscle aches, severe joint aches, and muscle cramping which continued at the time of report. The patient has been unable to continue lifting weights and doing cardio regularly as the patient had prior because of the pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the events muscle aches, severe joint aches, muscle cramping and pain were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Impotency, headaches, eye condition, memory loss, lack of concentration, joint condition, sleep problems, mucous membrane disorder (nasal), skin condition (whole body), stomach condition, depression, diabetes mellitus, burning sensation. Per 60 day follow up: Still present the symptoms submitted before. Meningococcal Conjugate vaccines stil do appear in this report.  10/10/2007 Lengthy MR received documenting multiple OVs, ER visits and surgeries from 12/2003 to present. Pt suffered a physical injury to lower back and shoulder in 3/2003. Pt treated for chronic low back pain which radiates to legs, sciatica. Had Right L4L5 Discectomy for herniated disc  6/2004 without resolution of symptoms.  Also had excision of shoulder lipoma 10/2004. Problem list as of 2/2007: Diabetes Mellitus Type 2, Dyslipidemia, Hypertension, Lumbar Disc Displacement. Post laminectomy syndrome of lumbar region, Pain, Depressive Disorder NOS, Chronic Low Back Pain, Myofascial Pain Syndrome, Cervicalgia, Pain in joint involving the shoulder region, muscular wasting and disuse atrophy. Pt has been diabled since surgery 6/2004. Treated for erectile dysfunction with medication and device. Followed in Chronic Pain Clinic and with Psych for related issues such as depression and sleep disorder. 1/12/2010 High fever, problems with the skin, diabetes type II, high blood presion, roling nose, loss of concentration, pain in the joints, headhache, problems of eyesight, sleep problems, Insomia and other symptoms related.
Pt had course of therapy in 1988 then 3 boosters 1988, 1989, & 30JUL91; only the 30JUL91 dose was Engerix-B pt has not responded;
About six hours after shot I started to notice weak, rubbery arms. Today, I was a little nauseous, very sore all over, and very tired.
Cellulitis of the injection site. At the time of visit, he had induration measuring 11 x 12 cm surrounding the injection site.
Red, warm, itchy Rash on upper arm of injection near injection site,  also on opposite elbow.  All over random itching (all started 10 days after 1 st injection).
There was no adverse event from the vaccination itself but we were advised to file a report in VAERS by the vaccine manufacturer because we were notified that a 17 year old received a first dose of the Moderna vaccine before it was realized that she was under age. She and her family reported no adverse reactions from the vaccine.
12 hrs p/vax woke up w/chills, muscle aches & h/a; these sx lasted approx 12 hrs; had only dull h/a the following day;
13-year-old patient received a dose of pediatric Pfizer 0.2mL instead of receiving 0.3mL dose.
Appx 2 weeks after injection a pimple formed at the injection site formed a scab and it fell off. Appx a couple weeks later another scab at injection site formed and fell off. Pt is still having itching at the injection site.
Extreme pain and redness in all joints. Felt like they were on fire. Now pain in joints continues down to my toe joints and I get shaky very easily and can not stand for long. I have not gone to the hospital as they are overrun with Covid patients. Have scheduled a doctor's appt since it hasn't resolved.
Left arm extremely sore after vaccination. A week later I told Dr it was still sore and was told that was normal. Several weeks later at primary Dr and said arm still sore and was told possibly a nerve was hit during injection and it should subside. Arm began to progressively get weaker and sore at times. Grip strength became weaker and lifting strength became weaker. Continued weakness from injection sight down to inner elbow area. Back at Dr to get to the bottom of the weakness and was put on prednisone. Some relief but day I stopped the pred everything was back, Weakness continued. Appt. now scheduled with a specialist.
This spontaneous report as received from a Medical Assistant via Field Employee refers to a patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX single dose (route, dose and lot # were unknown). Without any concomitant vaccination. On an unknown date the patient experienced "a herpes outbreak" after receiving ZOSTAVAX. The outcome was unknown. No additional information was available pertaining to recovery time, treatment or severity of outbreak. The patient sought medical attention via contacting physician. This is one of two reports from the same reporter. Additional information is not expected.
Headache, Fever, Diarrhea & NauseaVomiting  Narrative: Chills, Fever of 100.3 on 9/25/21.
Left deltoid was swollen, red, warm to the touch,  body aches, nauseous, and slight headache. Patient evaluated by physician.
Gout flare up left heel, had previously only had 1 episode of gout which was 4 years previously.  There had been no increase in consumption of purines since initial episode of gout 4 years previously.  Sore arm at site of injection.  Headache.  Muscle aches.  Lastly, since my cholecystectomy 30 years ago I have never had constipation and now I am experiencing severe constipation following the vaccine.
Fatigue, headache, dizziness, body aches on same day Two days later chest pains, joint pains
Administer doses from a vial that was punctured more than 12 hours ago and left at room temperature over-night; Administer doses from a vial that was punctured more than 12 hours ago and left at room temperature over-night; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer doses from a vial that was punctured more than 12 hours ago and left at room temperature over-night) and PRODUCT STORAGE ERROR in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer doses from a vial that was punctured more than 12 hours ago and left at room temperature over-night) and PRODUCT STORAGE ERROR. On 04-Jan-2022, EXPIRED PRODUCT ADMINISTERED and PRODUCT STORAGE ERROR had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter No treatment medications provided by the reporter.  Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F) - At 10:12 am it was removed from the fridge, yesterday 03Jan2022. It was administered today, 04Jan2022, at 11:15 am and 11:30 am.
a nodule removed from my thyroid; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THYROID MASS (medically significant), outcome "unknown", described as "a nodule removed from my thyroid". Therapeutic measures were taken as a result of thyroid mass.  Clinical course: The patient stated that 'I'm having a nodule removed from my thyroid. Any chance this occurred because of your covid vaccine? I imagine you're not allowed to reply for legal reasons."  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
completed that GARDASIL series with four administered doses of the vaccine; then received one dose of GARDASIL 9; then received one dose of GARDASIL 9; No adverse effects reported; This spontaneous report was received from a nurse referring to a non-pregnant female patient of unknown age. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported.       On an unknown date, at the age of 12-year-old, the patient was vaccinated with the first dose quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) intramuscularly for prophylaxis (anatomical location, lot # and expiration date were not reported). It was stated that the patient completed the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) series with four administered doses of the vaccine.   Then, on an unknown date, the patient received a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) intramuscularly, for prophylaxis (anatomical location, lot # and expiration date were not reported). No additional doses were administered to the patient. No adverse effects were reported.
death COVID-19 Pneumonia due to coronavirus disease 2019 Acute respiratory failure with hypoxia
I had diarrhea for over 60 days. I was then diagnosed with exocrine pancreatic insufficiency and microscopic colitis.  I did not have either of these before the booster.
Around 1:00 am after the injection on April 16, 2021, I developed headache, chills, muscle aches.  Only lasted 1 day.  I felt fine on April 18, 2021.
I have been Post menopausal for over 3 years now. And I woke up around midnight with the worst abdominal pains ever. Then I stared spotting and  I haven't stopped. My stomach cramps are not as bad but I still have them along with the spotting.
The patient received a dose of GARDASIL 9 where a healthcare worker did not shake the vaccine vial prior to administration; No adverse symptoms reported; This spontaneous report was received from a male consumer, referring to himself, the patient's age was not provided. The patient's pertinent medical history, concomitant therapies, as well as drug reactions or allergies were unknown.     On unspecified date, the patient  received a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported), the healthcare worker did not shook the vaccine vial prior to administration (wrong technique in product usage process), no adverse symptoms reported.